Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Evaxion Biotech A/S EVAX
$1.55
-$0.01 (-0.64%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
39392620.00000000
-
week52high
3.52
-
week52low
0.92
-
Revenue
0
-
P/E TTM
-1
-
Beta
0.55570900
-
EPS
-1.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:30
Описание компании
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Oppenheimer | Outperform | 02 мар 2021 г. | |
| Oppenheimer | Outperform | Outperform | 17 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Evaxion to present a full clinical readout on two personalized cancer immunotherapies in Q2 2023
GlobeNewsWire
15 дек 2022 г. в 07:48
COPENHAGEN, Denmark, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today announced that they expect to present data from their two clinical trials of personalized cancer immunotherapies (cancer vaccines) EVX-01 and EVX-02 in the second quarter of 2023.
Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today
PennyStocks
23 сент 2022 г. в 15:32
High volume penny stocks to watch before next week. The post Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Evaxion (EVAX) Enrolls First Patient in Phase IIb Melanoma Study
Zacks Investment Research
22 сент 2022 г. в 12:03
Evaxion (EVAX) enrolls the first patient in the phase IIb study evaluating its cancer therapy, EVX-01 in combination with Keytruda, for treating melanoma.
Good Penny Stocks to Add to Your Buy List? 3 to Watch
PennyStocks
22 сент 2022 г. в 06:00
Which penny stocks are on your buy list right now? The post Good Penny Stocks to Add to Your Buy List?
Why Is Evaxion Biotech (EVAX) Stock Up Today?
InvestorPlace
21 сент 2022 г. в 14:10
Today's price action (prior to the Federal Reserve's rate hike decision at least) has been broadly positive. But for investors in Evaxion Biotech (NASDAQ: EVAX ), it's been a heck of a day.